One integrated team. Every stage covered โ from study design and protocol development through site qualification, real-time quality review, advanced image analysis, and full reporting..
Examples of quantitative imaging analyses and biomarker outputs delivered across research and clinical development programs.
Automated lesion segmentation with volumetric and burden quantification by anatomical location, alongside a 3D lesion map.
Vertex-wise cortical thickness mapped across the cortical surface, with warmer colours indicating greater atrophy relative to normative reference values.
A whole-body reference template used to intrinsically co-register longitudinal PET, CT, and MR studies for a given patient, ensuring scans from different time points and modalities align to a common anatomical space for consistent, side-by-side radiology reporting
Precuneus seed-based resting-state connectivity, shown across axial, sagittal, and coronal slices, highlighting default-mode network coupling.
Region-to-region Fisher z-transformed correlation matrix across precuneus, posterior cingulate, inferior parietal, and superior frontal ROIs.
Our team has deep expertise in quantitative MRI techniques that generate reproducible, clinically meaningful biomarkers.
Dynamic contrast-enhanced MRI for perfusion and vascular permeability assessment.
Microstructural tissue characterisation including DTI, DKI, and IVIM modelling.
Oxygen-enhanced MRI for non-invasive assessment of tissue oxygenation and perfusion.
In vivo metabolite quantification for oncology, neuroimaging, and metabolic disease.
T1, T2, T2* and susceptibility mapping for tissue characterisation and iron quantification.
BOLD-based fMRI for neuroscience and CNS drug development biomarkers.
Ortex Solutions supports imaging across a broad range of biomarker development. MRI/PET/CT
Whether you're at the design stage or need support on an existing trial, our team is ready to help.
contact@ortexsolutions.com.au